Table 1.
Target Population | No. | % |
---|---|---|
Patients with ICD9-diagnosis of CAP during the enrollment window (June 30, 2011–May 30, 2015) | ||
Patients with ≥1 prescription fill for any of the 9 antibiotics of interest (amoxicillin, amoxicillin-clavulanate, ceftriaxone, azithromycin, clarithromycin, levofloxacin, moxifloxacin, ciprofloxacin, doxycycline) during the enrollment window within 3 days of CAP claim | 890 784 | 100.0 |
Exclusion Criteria | No. | % |
Patients without continuous enrollment in medical and pharmacy benefits for at least 12 months before the index date | 676 642 | 76.0 |
Patients without continuous enrollment in medical and pharmacy benefits for a minimum of 30 days after the index date | 654 105 | 73.4 |
Hospitalization for any reason within 2 days of index prescription claim | 618 326 | 69.4 |
Patients with prescription fills for any antibiotic in the 30 days before diagnosis of CAP | 508 384 | 57.1 |
Patients with medical claim containing a primary diagnosis of CAP in the 30 days before the first outpatient medical claim in the enrollment window | 498 408 | 56.0 |
Patients with HMO enrollment | 424 577 | 47.7 |
Patients on combination antibiotics | 413 801 | 46.5 |
Sample size after applying all pre- and postindex eligibility requirements | 413 801 | 46.5 |
Patients aged ≥18 years (final sample size) | 257 165 |
Of this population, 257 165 were aged ≥18 years and served as the primary focus of subsequent analysis.
Abbreviations: CAP, community-acquired pneumonia; HMO, Healthcare Maintenance Organization.
aSample size = 413 801 after all inclusion/exclusion criteria were met.